Treatment of early rheumatoid arthritis with certolizumab pegol after failure of diseasemodifying antirheumatic drugs: a report of two cases
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 2
Abstract
Rheumatoid arthritis is a severe systemic inflammatory disease, characterized by polyarticular synovitis and subsequent structural changes to the cartilage. Diagnosis and treatment in the early disease stages are extremely important, as disease evolution may cause articular deformities, leading to patient disability, worsened Quality of Life (QoL), and reduced survival. The main treatment objectives include decreasing the inflammatory process, controlling or blocking the evolution of osteoarticular lesions, and improving patient QoL. This article describes the evolution of two patients diagnosed with early rheumatoid arthritis with very aggressive characteristics and who, upon failure of treatment with disease-modifying antirheumatic drugs, successfully underwent therapy with certolizumab pegol.
Authors and Affiliations
Mario Newton Leitão de Azevedo
Keywords
Related Articles
- EP ID EP603249
- DOI -
- Views 65
- Downloads 0
A familial case of takayasu arteritis: HLA-related genetic susceptibility and efficacy of anti-TNFα treatment in two italian siblings
The aetiology of Takayasu Arteritis (TA) remains poorly understood. An autoimmune origin is the main hypothesis, suggesting an abnormal immune response against unknown antigens present on vessel walls. The genetic contri...
Application of treat-to-target principles in patients with early rheumatoid arthritis in routine clinical practice in Central-Eastern Europe
Objective: Understanding the extent to which treat-to-target (T2T) recommendations are applied by rheumatologists in patients with rheumatoid arthritis (RA) may identify gaps or issues in disease management. This study e...
Rituximab for granulomatous lymphocytic interstitial lung disease in a patient with common variable immunodeficiency. Is single therapy enough?
Abstract: Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) is an inflammatory pulmonary complication of common variable immunodeficiency (CVID) with distinctive patterns in the biopsy; Granulomatous Disease, L...
Increased prevalence of ANA and Anti-SSA in African American rheumatoid arthritis patients is not associated with increased serum chemokine concentrations
Background: African American (AA) rheumatoid arthritis (RA) patients have increased disease activity compared to Caucasian (CAU) RA patients. Serum chemokines, such as CXCL10, are increased in RA patients and may functio...
Recurrent life-threatening bleeding due to acquired clotting factor XIII inhibitor in a Chinese patient with systemic lupus erythematosus
A 52-year-old Chinese male with systemic lupus erythematosus presented with recurrent retroperitoneal haematoma and finally died of aggressive bleeding complications related to acquired clotting factor XIII inhibitor. We...